End of Year Challenge Grant Campaign Donations multiplied nearly 10X as Duke Researcher uses research results to secure $225,000 Grant from DIBS
Online PR News – 08-September-2015 – Rolesville, NC – Cure AHC, Inc. announces that its previous $45,000 Grant to Dr. Mohamad Mikati at Duke University has helped generate significant preliminary research data in Phase III of the Mouse Model of AHC project. This grant was made possible by the 2014 $25,000 Match Grant End of Year Campaign and awarded January, 2015.
Dr. Mikati has leveraged that data to secure an award from the Duke Institute for Brain Sciences. It’s officially called a 2015-2016 DIBS Research Incubator Award in the amount of $75,000 per year for the next 3 years for a total of $225,000. This means that donations Cure AHC received during the campaign have not only produced fruitful research data, but have also been multiplied nearly 10 fold to advance the research project even further.
“We consider Cure AHC’s investment in our research to be a very helpful component of the success in winning this award,” Dr. Mikati said.
Cure AHC will continue to provide seed funding for key research projects around the world. “We believe it is one of our core functions to make strategic and tactical investments in research projects such as the AHC Mouse Model Project, to empower these researchers to tap into larger funding sources like the DIBS,” said Cure AHC President Jeff Wuchich.
Cure AHC is working with several potential major donors to secure the funds for the 2015 End of Year Global Challenge Grant Campaign, with plans to roll out collateral for supporters to launch the campaign in late October in time for the Holiday Giving Season.
Alternating Hemiplegia of Childhood (AHC) is an incurable, rare and painful neurological disorder that causes episodes of temporary paralysis that last minutes or even days. AHC is often mistaken for cerebral palsy or epilepsy which impairs the ability to learn and communicate. AHC also affects muscle control, causing shallow breathing and difficulty walking and swallowing. Researchers discovered the gene that causes Alternating Hemiplegia of Childhood (AHC) in 2012 and they continue to make progress in their understanding of the disease, which aids in better treatment and ultimately a cure for AHC sufferers, as well as potential benefit to more mainstream diseases such as epilepsy, stroke, and heart disease.
Cure AHC is a 501 (c) 3 Non-profit organization that was created to raise awareness and research funds to develop a treatment and discover the cure for Alternating Hemiplegia of Childhood. Donations to Cure AHC can be made online through the www.cureahc.org or a check may be sent to Cure AHC, Inc. at 545 Irina Drive, Rolesville, NC 27571.
For more information about Alternating Hemiplegia of Childhood (AHC) please visit www.cureahc.org or contact email@example.com.